Search results
Biden administration strips federal funding from nonprofit at center of COVID lab leak controversy
Reason.com· 4 hours agoToday, the Biden administration suspended federal funding to the scientific nonprofit whose research...
Stop Spending Tax Dollars on NIH's Cruel Animal Experiments
Newsweek· 1 day agoProject's (WCW) viral #BeagleGate campaign uncovered that Dr. Fauci's division of the NIH—the...
Q1 2024 Ocugen Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 20 hours agoFinally, OCU500 as soon advanced into Phase 1 clinical trial via the National Institute of Allergy and Infectious Diseases, NIAID sponsor trial, comparing the administration ...
NIH official set to testify before COVID panel on ‘discrepancies’ in pandemic timeline
The Hill via Yahoo News· 6 days agoLawrence Tabak, principal deputy director of the National Institutes of Health (NIH), will testify...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 hours agoFortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a fourth BLA filing as early as 2025 FDA accepted New Drug Application filing for DFD-
Risk-Targeted Preventive TB Treatment Works, Particularly With Infection Testing
MedPage Today· 7 days agoLarge real-world analysis homes in on the best strategies in high- and low-burden settings
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoUT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine PR Newswire SAN ANTONIO, May 9, 2024 The University of Texas Health Science Center at San Antonio ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoAll three first-in-class modifier gene therapy product candidates currently in the clinic with OCU400 Phase 3 in progressOCU400 on track to meet 2026 Biologics License Application (BLA) and Market Authorization Application (MAA) approval targets